Publication:
SARS-CoV-2 IgG Antibody Levels After Inactivated Vaccine (CoronaVac) among Elderly

dc.contributor.authorDİNÇ, HARİKA ÖYKÜ
dc.contributor.authorBALKAN, İLKER İNANÇ
dc.contributor.authorbudak, beyhan
dc.contributor.authorDEMİRCİ, MEHMET
dc.contributor.authorÖZBEY, DOĞUKAN
dc.contributor.authorKARAALİ, RIDVAN
dc.contributor.authorMETE, BİLGÜL
dc.contributor.authorCAN, GÜNAY
dc.contributor.authorERGİN, SEVGİ
dc.contributor.authorKOCAZEYBEK, BEKİR SAMİ
dc.contributor.authorSALTOĞLU, NEŞE
dc.contributor.institutionauthorDİNÇ, HARİKA ÖYKÜ
dc.date.accessioned2022-06-14T20:59:13Z
dc.date.available2022-06-14T20:59:13Z
dc.date.issued2022-06-01T00:00:00Z
dc.identifier.citationDİNÇ H. Ö. , BALKAN İ. İ. , budak b., DEMİRCİ M., ÖZBEY D., KARAALİ R., METE B., CAN G., ERGİN S., KOCAZEYBEK B. S. , et al., -SARS-CoV-2 IgG Antibody Levels After Inactivated Vaccine (CoronaVac) among Elderly-, Infectious diseases and clinical microbiology (Online), cilt.4, sa.2, ss.140-143, 2022
dc.identifier.doi10.36519/idcm.2022.115
dc.identifier.urihttp://hdl.handle.net/20.500.12645/30746
dc.identifier.yoksis7710075
dc.titleSARS-CoV-2 IgG Antibody Levels After Inactivated Vaccine (CoronaVac) among Elderly
dc.typeArticle
dspace.entity.typePublication
local.avesis.ida9ec4ab4-9b3f-40d9-bac2-bdf746f30fc2
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational0
relation.isAuthorOfPublication6f44fd83-f5fa-4152-9576-c7c1d7ce6ad1
relation.isAuthorOfPublication.latestForDiscovery6f44fd83-f5fa-4152-9576-c7c1d7ce6ad1
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files